Pharmacokinetics of amikacin in cystic fibrosis: A study of bronchial diffusion
β Scribed by E. Autret; S. Marchand; M. Breteau; B. Grenier
- Publisher
- Springer
- Year
- 1986
- Tongue
- English
- Weight
- 402 KB
- Volume
- 31
- Category
- Article
- ISSN
- 0031-6970
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
We compared standard chest physical therapy and postural drainage (CPT/PD) with a new airway clearance therapy called high-frequency chest wall oscillation (HFCWO) in a group of stable cystic fibrosis (CF) patients. In this crossover trial, 29 CF patients (15 males, 14 females), aged 7-47 years that
Cystic fibrosis (CF) is an inherited disorder associated with severe inflammation and repeated bacterial infection and colonization in the lung. Airway epithelium is involved in defence against bacteria, but this system may be defective in CF. Pro-inflammatory cytokines can stimulate the expression
## for the Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis Summary. Cystic fibrosis (CF) is a complex illness characterized by chronic lung infection leading to deterioration in function and respiratory failure in over 85% of patients. An understanding of the risk fact